Thomas W. Beetham

VRDN

Thomas W. Beetham serves as Chief Operating Officer at Viridian Therapeutics, Inc. (VRDN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$117.0K

Total Sells

1 trades

$41.1K

Net Position

Net Buyer

$76.0K

Companies Traded

VRDN, DNTH

Active Period

Sep 2021 – Sep 2024

2 total trades

Most Recent

Buy VRDN

Sep 30, 2024 · $117.0K

Thomas W. Beetham's Insider Trading at Viridian Therapeutics, Inc. (VRDN)

Buys

1 · $117.0K

Sells

0 · $0.00

Total Shares Bought

5,000

Total Shares Sold

VRDN Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 30, 2024	Buy	5,000	$23.41	$117.0K	6,000

Thomas W. Beetham's Insider Trading at Dianthus Therapeutics, Inc. (DNTH)

Buys

0 · $0.00

Sells

1 · $41.1K

Total Shares Bought

Total Shares Sold

6,103

DNTH Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 20, 2021	Sell	6,103	$6.73	$41.1K	13,897

Related Insiders

Simrat Randhawa

officer: EVP, Head of R&D

DNTHSell · Sep 3, 2026

Jennifer Tousignant

officer: Chief Legal Officer

VRDNSell · Aug 20, 2026

Simon Read

director

DNTHSell · Aug 19, 2026

Adam M Veness

officer: SVP, General Counsel and Sec.

DNTHSell · Aug 11, 2026

Anne McGeorge

director

DNTHSell · Aug 11, 2026

Marino Garcia

director, officer: CEO AND PRESIDENT

DNTHSell · Aug 7, 2026

Ryan Savitz

officer: EVP, CFO & CBO

DNTHSell · Jul 13, 2026

Fairmount Funds Management LLC

director, 10 percent owner:

VRDNBuy · May 13, 2026

Explore More Insider Trading Data

VRDN Insider Trading Activity

View all insider trades at Viridian Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity